Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;77(2):173-207.
doi: 10.1128/MMBR.00052-12.

Role of pore-forming toxins in bacterial infectious diseases

Affiliations
Review

Role of pore-forming toxins in bacterial infectious diseases

Ferdinand C O Los et al. Microbiol Mol Biol Rev. 2013 Jun.

Abstract

Pore-forming toxins (PFTs) are the most common bacterial cytotoxic proteins and are required for virulence in a large number of important pathogens, including Streptococcus pneumoniae, group A and B streptococci, Staphylococcus aureus, Escherichia coli, and Mycobacterium tuberculosis. PFTs generally disrupt host cell membranes, but they can have additional effects independent of pore formation. Substantial effort has been devoted to understanding the molecular mechanisms underlying the functions of certain model PFTs. Likewise, specific host pathways mediating survival and immune responses in the face of toxin-mediated cellular damage have been delineated. However, less is known about the overall functions of PFTs during infection in vivo. This review focuses on common themes in the area of PFT biology, with an emphasis on studies addressing the roles of PFTs in in vivo and ex vivo models of colonization or infection. Common functions of PFTs include disruption of epithelial barrier function and evasion of host immune responses, which contribute to bacterial growth and spreading. The widespread nature of PFTs make this group of toxins an attractive target for the development of new virulence-targeted therapies that may have broad activity against human pathogens.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Generalized mechanism of pore formation by PFTs. Soluble PFTs bind membrane receptors, which leads to oligomerization and insertion of an aqueous pore into the plasma membrane (5). Note that during the oligomerization step, some PFTs remain associated with their receptor, whereas others have already disassociated at this point.
Fig 2
Fig 2
Protein structures of various PFT classes. (A and B) Structures of a single molecule (A) and an assembled pore (B) of the E. coli α-PFT HlyE (295, 296) (Protein Data Bank [PDB] accession number 1QOY). (C) Structure of aerolysin, a β-PFT produced by A. hydrophila (485) (PDB accession number 1PRE). (D) PFO monomer (83) (PDB accession number 1PFO). (E) Hypothetical arrangement of CDC monomers into an assembled pore. This image was created by mapping PFO monomers onto a PLY cryo-electron microscopy (cryo-EM) image (180) (PDB accession number 2BK1). Structures were visualized using PyMOL (D) or MMDB (486) (A to C and E).
Fig 3
Fig 3
Overview of global in vivo effects of PFTs. Note that not all pathways are relevant to all toxins and hosts.
Fig 4
Fig 4
Overview of host pathways that are activated by PFTs. Note that not all pathways are relevant to all toxins and hosts.
None
None
None
None

Similar articles

Cited by

References

    1. Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science 325:1089–1093 - PMC - PubMed
    1. Woodford N, Livermore DM. 2009. Infections caused by Gram-positive bacteria: a review of the global challenge. J. Infect. 59(Suppl 1):S4–S16 - PubMed
    1. Huttner B, Goossens H, Verheij T, Harbarth S. 2010. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect. Dis. 10:17–31 - PubMed
    1. Alouf JE. 2003. Molecular features of the cytolytic pore-forming bacterial protein toxins. Folia Microbiol. (Prague) 48:5–16 - PubMed
    1. Gonzalez MR, Bischofberger M, Pernot L, van der Goot FG, Freche B. 2008. Bacterial pore-forming toxins: the (w)hole story? Cell. Mol. Life Sci. 65:493–507 - PMC - PubMed

MeSH terms

Substances